S.Pharm Pharmaceutical Joint Stock Company
Similar suppliers you may like
SPM Joint Stock Company
🇻🇳 Vietnam
19951001-2000 peopleManufacturer/Distributor/Trading CompanyHigh capacity factory
Established brand
Large enterprise group
Own brand
Shipments
2
Key customer
AALA AAMIN PHARMACEUTICAL
Key market
🇸🇬 Singapore
Description
SPM Joint Stock Company is a leading Vietnamese pharmaceutical manufacturer and distributor headquartered in Ho Chi Minh City. Established in 1995 and evolving from a distribution background dating back to the early 1980s, the company has grown into a major enterprise with a workforce of over 1,000 employees. SPM operates a modern manufacturing facility in the Tan Tao Industrial Park, which is equipped with advanced production lines that comply with GMP-WHO, ISO 9001, and ISO 14001 standards. The company specializes in a broad range of healthcare solutions, including vitamins, minerals, health supplements, analgesics, antibiotics, and cardiovascular medications. Notable product lines include the MyVita series of effervescent tablets and MyPara pain relievers. Beyond pharmaceuticals, SPM produces functional foods, herbal remedies, and medical equipment such as face masks. As an integrated business, SPM provides OEM services and maintains a robust national distribution network supported by large-scale, climate-controlled warehouses. The company has successfully expanded its footprint into international markets, maintaining a presence in the United States, Singapore, Myanmar, and Malaysia.
My Vita Strong
MyVita C Strong
MyVita Strong Sa+Gung Chanh
MyVita Strong
My Vita Power
Imexpharm Pharmaceutical Joint Stock Company
🇻🇳 Vietnam
19771001-2000 peopleManufacturer/DistributorHigh capacity factory
Established brand
Large enterprise group
OEM manufacturer
Shipments
4
Key customer
BURYAT OMBOL
Key market
Europe
Description
Imexpharm Pharmaceutical Joint Stock Company is a premier Vietnamese pharmaceutical manufacturer and distributor with over 48 years of industry experience. Headquartered in Cao Lanh, the company operates four major manufacturing clusters across Dong Thap, Ho Chi Minh City, and Binh Duong. Imexpharm is a leader in high-tech pharmaceutical production, maintaining 11 production lines that meet stringent EU-GMP standards, alongside WHO-GMP, GMP-ASEAN, and ISO 9001:2015 certifications. The company employs between 1,001 and 2,000 professionals and maintains a robust distribution network of 20 sales branches nationwide.
Specializing in both the Ethical (ETC) and Over-the-Counter (OTC) channels, Imexpharm is the leading domestic brand in the Vietnamese antibiotics market. Its extensive product portfolio includes Penicillins, Cephalosporins, and injectable antibiotics produced using advanced enzymatic technology. Beyond antibiotics, the company manufactures a wide range of therapeutic solutions for cardiovascular health, diabetes, musculoskeletal conditions, respiratory systems, and digestive health, as well as vitamins and health supplements. Their dosage forms include lyophilized injections, dispersible tablets, hard capsules, and oral suspensions.
As a key player in international trade, Imexpharm has successfully registered 28 Market Authorization Units (MAUs) in Europe, demonstrating its capability to meet global quality benchmarks. The company provides contract manufacturing and OEM services, collaborating with multinational partners such as Sandoz, Sanofi-Aventis, and Pharmacience Canada. Backed by strategic investment from South Korea's SK Group, Imexpharm continues to expand its R&D capabilities and non-antibiotic product lines to serve both domestic healthcare needs and international export markets.
Thực Phẩm Bảo Vệ Sức Khỏe
Vitamin & khoáng chất
Nhóm dùng ngoài
Diệt trừ ký sinh trùng
Tiểu đường
Tiêu hóa gan mật
Giãn mạch ngoại biên và hoạt hóa não
Kháng Histamin & Kháng dị ứng
Hệ hô hấp
Giảm đau - kháng viêm - hạ sốt
Cơ xương khớp
Mắt
